Riskpilot← Back to searchSign inGet full accessJolanta Sabockiene AB
ABActiveOrg 5569371817Hamnvägen 1Medical specialists activities · NACE 8622Est. 20130 employees
Revenue 2024
SEK 667K
-24% vs 2023
EBITDA margin
-29.8%
-210% vs 2023
Equity ratio
82.3%
Financial strength
Net profit 2024
SEK -37K
-122% vs 2023
| Revenue | SEK 667K | -24% |
| EBITDA | SEK -199K | -210% |
| Net profit | SEK -37K | -122% |
| Total assets | SEK 3,2M | -10% |
| Equity | SEK 2,7M | -8% |
| Employees | 0 | — |
Legal name
Jolanta Sabockiene AB
Org number
5569371817
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
11 juli 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva specialistverksamhet inom öppenvård samt därmed förenlig verksamhet, bolaget skall även förvalta fast egendom, aktier och andra värdepapper samt därmed förenlig verksamhet.
Address
Hamnvägen 1
Email
jolanta.sabockiene@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 893 | 828 | 1 115 | 872 | 667 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 436 | 511 | 732 | 181 | −199 |
| Depreciation & amort. | −75 | −75 | −0 | −0 | −0 |
| EBIT | 361 | 436 | 732 | 181 | −199 |
| Net financials | 4 | 3 | — | 36 | 40 |
| Profit before tax | 281 | 486 | 691 | 218 | −37 |
| Tax | −65 | −106 | −149 | −51 | −0 |
| Net profit | 216 | 380 | 542 | 167 | −37 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 085 | 3 209 | 3 628 | 3 591 | 3 234 |
| Equity | 2 383 | 2 579 | 2 934 | 2 905 | 2 663 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 93 | 68 | 92 | 84 | 91 |
| Total debt | 93 | 68 | 92 | 84 | 91 |
EBITDA margin
-29.8%
This company
15.8%
Market median
-289% vs market
20202024
Equity ratio
82.3%
This company
38.2%
Market median
+115% vs market
20202024
Return on equity
-1.4%
This company
18.4%
Market median
-108% vs market
20202024
Net profit margin
-5.5%
This company
8.1%
Market median
-168% vs market
20202024
Asset turnover
0.21×
This company
1.12×
Market median
-81% vs market
20202024
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2024 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Jolanta Sabockiene AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jolanta Sabockiene | Board of Directors | 0 companies |
| Dagne Ginvile Sabockis | Deputy Board Member | 0 companies |
| Liudas Sabockis | Deputy Board Member | 0 companies |